Tecan Annual Report
Tecan Annual Report





CHF 1,000



Balance at January 1






Reversed (included in other operating income)



Translation differences






Balance at December 31






Thereof current



Thereof non-current




In October 2020, the U.S. Department of Defense and the U.S. Department of Health and Human Services awarded a government grant of USD 32.9 million to launch new production capacities in the U.S. for pipette tips, which are key components for COVID-19 tests. The amount was fully paid to the Group at year-end 2022 (CHF 30.4 million). The related production lines are reported in position property, plant and equipment and were ready for use since April 2023. Consequently, the Group has started to reverse the government grant in the consolidated statement of profit or loss in proportion to the depreciation amount.